Published in:
Open Access 01-12-2023 | Radiation Protection | Original Article
European survey on the use of patient contact shielding during radiological examinations
Published in: Insights into Imaging | Issue 1/2023
Login to get accessAbstract
Objectives
Contact shielding (CS) of patients during X-ray studies has been used for decades to protect radiosensitive organs. This practice has not changed much despite increasing evidence that CS is not useful in many cases. The Gonad And Patient Shielding (GAPS) group—founded by representatives of the main European bodies involved in radiology—promoted this survey to assess the current practice of CS among European radiology departments and the attitude towards a non-shielding policy.
Methods
Over a four-month period (15 May–15th September 2021) European Society of Radiology and European Society of Paediatric Radiology radiologist members were invited to respond to a web-based questionnaire consisting of 59 questions.
Results
225 centres from 35 countries responded to this survey. CS was routinely applied in at least one radiological modality in 49.2% of centres performing studies in adults, 57.5% of centres performing studies in children, and 47.8% of centres performing studies on pregnant women. CS was most frequently used in conventional radiography, where the most frequently shielded organs were the gonads, followed by thyroid, female breasts, and eye lens. 83.6% respondents would follow European recommendations on the use of CS when provided by the main European bodies involved in radiology.
Conclusions
This review shows that CS is still largely used across Europe. However, a non-shielding policy could be adopted in most departments if European professional societies provided recommendations. In this regard, a strong commitment by European and national professional societies to educate and inform practitioners, patients and carers is paramount.
Clinical relevance statement
According to this survey expectations of patients and carers, and skepticism among
professionals about the limited benefits of CS are the most important obstacles to the application of a no-shielding policy. A strong commitment from European and national professional societies to inform practitioners, patients and carers is fundamental.
Graphical Abstract
×
![]()